CN101180267B - 胺和氨基酸的苯基-n-酰基衍生物、其制备过程、其药物组合物和用途 - Google Patents

胺和氨基酸的苯基-n-酰基衍生物、其制备过程、其药物组合物和用途 Download PDF

Info

Publication number
CN101180267B
CN101180267B CN200680017304.2A CN200680017304A CN101180267B CN 101180267 B CN101180267 B CN 101180267B CN 200680017304 A CN200680017304 A CN 200680017304A CN 101180267 B CN101180267 B CN 101180267B
Authority
CN
China
Prior art keywords
compound
general formula
pharmaceutically acceptable
compounds
inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200680017304.2A
Other languages
English (en)
Chinese (zh)
Other versions
CN101180267A (zh
Inventor
V·E·涅博利辛
T·A·克罗莫娃
G·A·热尔图欣娜
V·L·科瓦廖娃
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OBSCHESTVO S OGRANICHENNOI OTV
Original Assignee
OBSCHESTVO S OGRANICHENNOI OTV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by OBSCHESTVO S OGRANICHENNOI OTV filed Critical OBSCHESTVO S OGRANICHENNOI OTV
Publication of CN101180267A publication Critical patent/CN101180267A/zh
Application granted granted Critical
Publication of CN101180267B publication Critical patent/CN101180267B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/12—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
    • C07C233/13—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/14—Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/11—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/22—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/51—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN200680017304.2A 2005-03-25 2006-03-24 胺和氨基酸的苯基-n-酰基衍生物、其制备过程、其药物组合物和用途 Expired - Fee Related CN101180267B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2005108492 2005-03-25
RU2005108492/04A RU2309144C2 (ru) 2005-03-25 2005-03-25 Фенилсодержащие n-ацильные производные аминов, способ их получения, фармацевтическая композиция и их применение в качестве противовоспалительных и анальгетических средств
PCT/RU2006/000139 WO2006101422A1 (fr) 2005-03-25 2006-03-24 Derives n-acyles d'amines et d'acides amines amines contenant des phenyles, procede de fabrication, composition pharmaceutique et son utilisation

Publications (2)

Publication Number Publication Date
CN101180267A CN101180267A (zh) 2008-05-14
CN101180267B true CN101180267B (zh) 2015-06-17

Family

ID=37024023

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200680017304.2A Expired - Fee Related CN101180267B (zh) 2005-03-25 2006-03-24 胺和氨基酸的苯基-n-酰基衍生物、其制备过程、其药物组合物和用途

Country Status (18)

Country Link
US (2) US8309766B2 (enExample)
EP (1) EP1876169B1 (enExample)
JP (1) JP5384096B2 (enExample)
KR (1) KR101383580B1 (enExample)
CN (1) CN101180267B (enExample)
CA (1) CA2602545C (enExample)
CY (1) CY1117449T1 (enExample)
DK (1) DK1876169T3 (enExample)
EA (1) EA013644B1 (enExample)
ES (1) ES2564238T3 (enExample)
HU (1) HUE027009T2 (enExample)
MX (1) MX2007011852A (enExample)
PL (1) PL1876169T3 (enExample)
PT (1) PT1876169E (enExample)
RU (1) RU2309144C2 (enExample)
SI (1) SI1876169T1 (enExample)
UA (1) UA88688C2 (enExample)
WO (1) WO2006101422A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4667870B2 (ja) 2002-10-03 2011-04-13 ノヴァレメッド リミテッド 自己免疫疾患、免疫−アレルギー疾患及び臓器又は組織移植拒絶反応の治療において使用する新規な化合物
US7674829B2 (en) 2004-03-26 2010-03-09 Novaremed Limited Compounds for the treatment of AIDS and other viral diseases
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
RU2474573C2 (ru) * 2008-04-29 2013-02-10 Ф.Хоффманн-Ля Рош Аг Производные 4-диметиламиномасляной кислоты
ES2770362T3 (es) * 2009-09-09 2020-07-01 Novaremed Ltd Bencenopropanamida N-sustituida para su uso en el tratamiento del dolor y la inflamación
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
CN103221383B (zh) * 2010-08-27 2016-04-20 株式会社新药 促进人源性抗菌肽分泌的新化合物、其制备方法以及含有其作为活性成分的组合物
GB201116335D0 (en) * 2011-09-21 2011-11-02 Novaremed Ltd A method of treating or preventing affective disorders
ES2578377B1 (es) 2014-12-22 2017-05-04 Consejo Superior De Investigaciones Científicas (Csic) Compuestos moduladores del sensor neuronal de calcio dream y sus usos terapéuticos.
RU2690188C2 (ru) * 2017-05-26 2019-05-31 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Новый мультитаргетный препарат для лечения заболеваний у млекопитающих
JP2021509398A (ja) 2017-08-21 2021-03-25 プレックス ファーマスーティカルズ，インク 二重作用ｆｋｂｐ１２およびｆｋｂｐ５２阻害剤
RU2678563C1 (ru) * 2017-10-27 2019-01-30 Михаил Владимирович Овчинников Водорастворимые производные тирозина, обладающие анальгетическим, противовоспалительным и противоотечным действием
RU2697414C1 (ru) * 2018-05-11 2019-08-14 Общество с ограниченной ответственностью "АЙ БИ ДИ Терапевтикс" Новый антагонист тахикининовых рецепторов и его применение
RU2727703C2 (ru) * 2018-10-29 2020-07-23 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Новый способ получения (S)-2-(2-(4-гидроксифенил)ацетамидо)-3-фенилпропановой кислоты
RU2716258C1 (ru) * 2019-07-30 2020-03-11 Автономная некоммерческая образовательная организация высшего образования Сколковский институт науки и технологий Пептидный антагонист нмда-рецептора

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5912225A (en) * 1997-04-14 1999-06-15 Johns Hopkins Univ. School Of Medicine Biodegradable poly (phosphoester-co-desaminotyrosyl L-tyrosine ester) compounds, compositions, articles and methods for making and using the same

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2711656A1 (de) * 1977-03-17 1978-09-21 Basf Ag Neue pyridin-3-ole
EP0000252B1 (en) * 1977-06-29 1982-02-03 Beecham Group Plc Peptides, pharmaceutical compositions containing the peptides and a process for the preparation of the peptides
JPS57145891A (en) * 1981-03-05 1982-09-09 Sagami Chem Res Center Optically active diphosphine ligand
JPS57193437A (en) * 1981-05-21 1982-11-27 Ajinomoto Co Inc Amino acid derivative
ES8607214A1 (es) * 1985-10-16 1986-06-01 Gema Sa Procedimiento enzimatico de resolucion de n-fenilacetil-ami-nocompuestos y purificacion de sus isomeros opticamente ac- tivos
USRE37160E1 (en) 1990-06-12 2001-05-01 Rutgers, The State University Synthesis of tyrosine derived diphenol monomers
US5403851A (en) * 1994-04-05 1995-04-04 Interneuron Pharmaceuticals, Inc. Substituted tryptamines, phenalkylamines and related compounds
AU1463997A (en) * 1995-12-22 1997-07-17 Acea Pharmaceuticals, Inc. Subtype-selective nmda receptor ligands and the use thereof
US6319492B1 (en) * 1996-11-27 2001-11-20 Rutgers, The State University Copolymers of tyrosine-based polyarylates and poly(alkylene oxides)
JPH11127894A (ja) * 1997-10-30 1999-05-18 Ono Pharmaceut Co Ltd カルボキシペプチダーゼａ活性測定方法および測定用キット
RU2123041C1 (ru) * 1998-04-02 1998-12-10 Пипия Гулади Эрастович Бальзам "саратовский"
JP4312384B2 (ja) * 1998-04-13 2009-08-12 ラットガーズ ザ ステイト ユニヴァーシティ コポリマーライブラリーの構築
WO1999055330A1 (en) * 1998-04-27 1999-11-04 Smithkline Beecham Corporation Ccr-3 receptor antagonists
US6414173B1 (en) * 1998-07-02 2002-07-02 University Of Maryland Hypervalent silane and siloxane derivatives and the use thereof
EP1178043B1 (en) * 2000-03-09 2005-12-28 Tokuyama Corporation Method for storing quaternary ammonium salt
HUP0303085A2 (hu) * 2000-09-27 2003-12-29 The Procter & Gamble Co. Melanokortin receptor ligandumok és ezeket tartalmazó gyógyszerkészítmények
JP4667870B2 (ja) * 2002-10-03 2011-04-13 ノヴァレメッド リミテッド 自己免疫疾患、免疫−アレルギー疾患及び臓器又は組織移植拒絶反応の治療において使用する新規な化合物
RU2233289C2 (ru) * 2002-11-04 2004-07-27 Институт органического синтеза Уральского отделения РАН Способ получения дипептидов

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5912225A (en) * 1997-04-14 1999-06-15 Johns Hopkins Univ. School Of Medicine Biodegradable poly (phosphoester-co-desaminotyrosyl L-tyrosine ester) compounds, compositions, articles and methods for making and using the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ALESSANDRA BASSO ET AL..QUANTITATIVE ACYLATION OF AMINO COMPOUNDS CATALYSED BY PENICILLIN G ACYLASE IN ORGANIC SOLVENT AT CONTROLLED WATER ACTIVITY.《CROATICA CHEMICA ACTA》.2001, *

Also Published As

Publication number Publication date
SI1876169T1 (sl) 2016-05-31
PL1876169T3 (pl) 2016-06-30
WO2006101422A1 (fr) 2006-09-28
KR20080008345A (ko) 2008-01-23
ES2564238T3 (es) 2016-03-21
US8309766B2 (en) 2012-11-13
JP2008534495A (ja) 2008-08-28
CA2602545A1 (en) 2006-09-28
RU2005108492A (ru) 2006-10-10
RU2309144C2 (ru) 2007-10-27
EP1876169A4 (en) 2009-11-04
EP1876169A1 (en) 2008-01-09
EA200702072A1 (ru) 2008-02-28
PT1876169E (pt) 2016-03-21
CY1117449T1 (el) 2017-04-26
UA88688C2 (ru) 2009-11-10
KR101383580B1 (ko) 2014-04-09
DK1876169T3 (en) 2016-03-07
HUE027009T2 (en) 2016-10-28
CN101180267A (zh) 2008-05-14
US20130109880A1 (en) 2013-05-02
US20090111874A1 (en) 2009-04-30
CA2602545C (en) 2014-08-19
EP1876169B1 (en) 2015-12-30
JP5384096B2 (ja) 2014-01-08
HK1118798A1 (en) 2009-02-20
MX2007011852A (es) 2008-02-21
EA013644B1 (ru) 2010-06-30
US8546612B2 (en) 2013-10-01

Similar Documents

Publication Publication Date Title
CN101180267B (zh) 胺和氨基酸的苯基-n-酰基衍生物、其制备过程、其药物组合物和用途
TWI286474B (en) Novel esters that are derived from indolealkanols and novel amides that are derived from indolealkylamines and the esters and the amides are selective COX-2 inhibitors
Mishra et al. Synthesis, characterization and pharmacological evaluation of amide prodrugs of ketorolac
AU2002320490B2 (en) N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
SK277877B6 (en) Indole derivatives, method of production and pharmaceutical agents containing them
AU2002320490A1 (en) N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
CN102573845A (zh) 新的阿片样物质的二羧酸连接的氨基酸和肽前药及其用途
AU2010272233A1 (en) Novel carbamate amino acid and peptide prodrugs of opioids and uses thereof
JPH08119923A (ja) グリシンアミド誘導体、その製法およびそれを含有する医薬
JP2001510441A (ja) ホスホジエステラーゼ４阻害剤としてのジアゼピノインドール
Mishra et al. Synthesis, characterization and pharmacological evaluation of amide prodrugs of flurbiprofen
KR20120046268A (ko) 갈란타민 아미노산과 펩티드 프로드러그 및 이들의 용도
Varnavas et al. Anthranilic acid derivatives: a new class of non-peptide CCK1 receptor antagonists
JPS5865260A (ja) ３−アミノ−２−ヒドロキシ−４−フエニル酪酸誘導体および医薬組成物
TW200911757A (en) Crystalline forms of histone deacetylase inhibitors
HK1118798B (en) Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof
CN109851573B (zh) 一种沃替西汀氨基酸酰胺类化合物及其制备方法和应用
CN108779146A (zh) 肽衍生物及其用途
CN116496178B (zh) 具有丁香酸和氨基酸结构片段的化合物及其合成与用途
Abo-Ghalia et al. Synthesis and anti-phlogistic potency of some new non-proteinogenic amino acid conjugates of “Diclofenac”
DHANESHWAR EXPLORING D-PHENYLALANINE AS A GASTRO-PROTECTIVE CHEMICAL DELIVERY SYSTEM FOR ACECLOFENAC SUNEELA DHANESHWAR*, R. BUCHADE1, A. SUTAR1, H. KARANDIKAR1 AND K. TEWARI1
Murdza Microwave Assisted Synthesis of Medicinally Relevant Indole Conjugates Utilizing Modified Hemetsberger-Knittel Indole Synthesis
JPH06206859A (ja) Ｎ−アシル−５−アミノスルホンアニリド化合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1118798

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1118798

Country of ref document: HK

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150617

CF01 Termination of patent right due to non-payment of annual fee